These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13399061)

  • 21. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical results with BZ 55 in the treatment of diabetes].
    ROCCA FF; CASTIGLIONI TRIANON CA; GIANETTO JC
    Dia Med; 1957 May; 29(30):860; passim. PubMed ID: 13447691
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood protein values and oral antidiabetic drugs; with a contribution to the statistical evaluation of median value differences reported without dispersion parameter].
    KUHNE P; SCHULTZ GW
    Arztl Wochensch; 1957 Feb; 12(5):112-5. PubMed ID: 13402613
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical comparison of carbutamide (BZ 55) and tolbutamide (D 860) treatment of diabetes mellitus; preliminary results of a combined therapy with both drugs].
    INTROZZI P; MARIGO S
    Prog Med (Napoli); 1957 Feb; 13(3):65-72. PubMed ID: 13420208
    [No Abstract]   [Full Text] [Related]  

  • 25. [Criteria for selection of diabetics to be treated with oral hypoglycemic drugs; test for sensitivity to sulfonylurea compounds].
    ARDUINO F
    Med Cir Farm; 1957 May; (253):187-98. PubMed ID: 13450825
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials with a new antidiabetic.
    WEILL J; WEIGEL M
    Strasb Med; 1956 Dec; 7(11):828-38. PubMed ID: 13422046
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new antidiabetic drug, B Z 55].
    BILHAN N; KARKALAS Y
    Turk Tip Cemiy Mecm; 1956 Sep; 22(9):503-17. PubMed ID: 13391990
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of new hypoglycemizing sulfonamides; BZ 55 and D 680; 20 case reports].
    HERBEUVAL R; CUNY G; LARCAN A
    Rev Med Nancy; 1957 Mar; 82():257-64. PubMed ID: 13442233
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes in glycemia and urea excretion in fasting diabetics treated with sulfanil-n-butyl urea].
    FEDELI S; MAGGI G; RIZZOLINI G
    Arch Sci Med (Torino); 1957 May; 103(5):361-7. PubMed ID: 13445444
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinical trial of carbutamide (BZ 55) in the diabetic clinic.
    BAILEY MJ; GRAYCE I; HERMAN JB; HOFFENBERG R; JACKSON WP; LINDER GC; WEINBERG R
    S Afr Med J; 1956 Dec; 30(51):1227-30. PubMed ID: 13391103
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical tests of the antidiabetic sulfa drugs.
    EICHBAUM FW
    Rev Bras Med; 1957 Jan; 14(1):5-11. PubMed ID: 13442028
    [No Abstract]   [Full Text] [Related]  

  • 32. [The current place of hypoglycemic sulfonamides (BZ 55) and similar products (D 860) in diabetic control].
    BASTENIE PA
    Brux Med; 1957 Mar; 37(13):499-506. PubMed ID: 13426651
    [No Abstract]   [Full Text] [Related]  

  • 33. The antidiabetic sulphonamides. Proc. Soc. Endocr. 60th.
    DUNLOP DM; BAIRD JD; DUCAN LJ
    J Endocrinol; 1957 Jun; 15(2):xlv-xlviii; discussion, xlviii-li. PubMed ID: 13439109
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood transaminases as indication of tolerance to antidiabetic sulfanylurea].
    PELLEGRINI R
    Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1454-5. PubMed ID: 13446088
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemistry and pharmacology of a new peroral antidiabetic: ambolin].
    NOHARA FS
    Praxis; 1957 Apr; 46(16):359-61. PubMed ID: 13441532
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical data in diabetics treated with sulfanil-n-butyl urea].
    TAMBUSCIO S; FALETRA G
    Arch Sci Med (Torino); 1957 May; 103(5):355-60. PubMed ID: 13445443
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects butyl-sulfonyl urea on blood lipids in diabetics].
    CORSINI G; GUACCI L
    Minerva Med; 1957 Apr; 48(27):1119-24. PubMed ID: 13440686
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oral antidiabetic therapy with sulfanylurea].
    MASSOBRIO E; BOGLIONE G; FABIANI A; PESCE L
    Minerva Med; 1957 Apr; 48(34):1537-54. PubMed ID: 13451332
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute agranulocytosis with acute renal insufficiency, fatal during a dermatosis caused by the anti-diabetic drug BZ 55].
    VARELA FUENTES B; CANZANI R; MILSTEIN I
    Arch Mal Appar Dig Mal Nutr; 1957 Apr; 46(4):305-11. PubMed ID: 13435983
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical contribution to the study of antidiabetic effect of NI-sulfamilyl-N2-n-Butyl carbamide].
    LAURIA D; NICOLETTI MN; ASCIONE A
    Riforma Med; 1957 Jun; 71(25):697-8. PubMed ID: 13454517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.